| Protara Therapeutics, Inc. TARA | $10.8M | 13.08 | 2.69M | 0% | +$0 | 1.71 | |
| Harrow Health, Inc. HROW | $51.87M | 11.08 | 3.92M | +2.63% | +$1.33M | 8.19 | |
Eton Pharmaceuticals, Inc. ETON | $9.17M | 9.52 | 2.45M | -3.32% | -$315,397.51 | 1.45 | |
| Codexis, Inc. CDXS | $10.89M | 4.42 | 3.12M | +2.44% | +$259,917.75 | 1.72 | |
| Ocular Therapeutix, Inc. OCUL | $60.54M | 4.3 | 6.65M | +9.61% | +$5.31M | 9.56 | |
| Trevi Therapeutics, Inc. TRVI | $9.13M | 3.76 | 2.65M | +4.34% | +$379,500.00 | 1.44 | |
| Syros Pharmaceuticals, Inc. SYRS | $4.21M | 2.95 | 787,545 | +119.15% | +$2.29M | 0.67 | |
Jasper Therapeutics, Inc. JSPR | $12.79M | 2.89 | 435,573 | -89.07% | -$104.22M | 2.02 | |
| Allakos Inc. ALLK | $3.07M | 2.75 | 2.44M | New | +$3.07M | 0.48 | |
| Relmada Therapeutics, Inc. RLMD | $3.53M | 2.52 | 759,000 | -13.46% | -$548,700.00 | 0.56 | |
| Compass Therapeutics, Inc. CMPX | $6.28M | 2.3 | 3.17M | New | +$6.28M | 0.99 | |
| XOMA Corporation XOMA | $6.01M | 2.15 | 250,000 | 0% | +$0 | 0.95 | |
| Aligos Therapeutics, Inc. ALGS | $1.6M | 2.09 | 1.63M | +25.68% | +$326,340.00 | 0.25 | |
| Ventyx Biosciences, Inc. VTYX | $7.07M | 1.82 | 1.28M | +12.72% | +$797,500.00 | 1.12 | |
Acelyrin, Inc. SLRN | $10.66M | 1.6 | 1.58M | -61.89% | -$17.32M | 1.68 | |
| Applied Therapeutics, Inc. APLT | $3.66M | 1.55 | 1.77M | +62.01% | +$1.4M | 0.58 | |
| Context Therapeutics Inc. CNTX | $1.53M | 1.48 | 1.11M | +13.68% | +$184,032.70 | 0.24 | |
| TG Therapeutics, Inc. TGTX | $34.68M | 1.48 | 2.28M | +2.94% | +$988,650.00 | 5.48 | |
| Lyell Immunopharma, Inc. LYEL | $7.48M | 1.32 | 3.35M | New | +$7.48M | 1.18 | |
| Gossamer Bio, Inc. GOSS | $2.88M | 1.08 | 2.44M | -18.18% | -$639,667.46 | 0.46 | |
| Keros Therapeutics, Inc. KROS | $24.33M | 1.02 | 367,500 | +2.8% | +$662,000.00 | 3.84 | |
Nyxoah S.A. NYXH | $4.32M | 0.94 | 320,000 | -7.19% | -$334,552.00 | 0.68 | |
| PMV Pharmaceuticals, Inc. PMVP | $802,130.00 | 0.92 | 471,481 | New | +$802,130.00 | 0.13 | |
| Catalyst Pharmaceuticals, Inc. CPRX | $16.01M | 0.85 | 1M | -20.11% | -$4.03M | 2.53 | |
| Rhythm Pharmaceuticals, Inc. RYTM | $22.31M | 0.85 | 515,000 | -15.57% | -$4.12M | 3.52 | |
| Verastem, Inc. VSTM | $2.49M | 0.84 | 211,400 | 0% | +$0 | 0.39 | |
| Revance Therapeutics, Inc. RVNC | $3.86M | 0.75 | 785,000 | New | +$3.86M | 0.61 | |
| UroGen Pharma Ltd. URGN | $4.05M | 0.75 | 270,000 | -15.63% | -$750,000.00 | 0.64 | |
| Edgewise Therapeutics, Inc. EWTX | $12.13M | 0.71 | 665,000 | -4.86% | -$620,160.00 | 1.92 | |
| 4D Molecular Therapeutics, Inc. FDMT | $10.96M | 0.67 | 344,123 | +11.55% | +$1.13M | 1.73 | |
| Savara Inc. SVRA | $4.26M | 0.62 | 855,000 | New | +$4.26M | 0.67 | |
| Liquidia Corporation LQDA | $5.83M | 0.52 | 395,000 | -11.24% | -$737,500.00 | 0.92 | |
| Arvinas, Inc. ARVN | $13.62M | 0.48 | 330,000 | +25.14% | +$2.74M | 2.15 | |
| Biodesix, Inc. BDSX | $764,560.00 | 0.47 | 534,657 | +7.68% | +$54,564.54 | 0.12 | |
| Precigen, Inc. PGEN | $1.37M | 0.38 | 947,500 | -6.42% | -$94,250.00 | 0.22 | |
| Iovance Biotherapeutics, Inc. IOVA | $13.29M | 0.32 | 897,000 | 0% | +$0 | 2.1 | |
| Zentalis Pharmaceuticals, Inc. ZNTL | $3.15M | 0.28 | 200,000 | New | +$3.15M | 0.5 | |
| Larimar Therapeutics, Inc. LRMR | $1.32M | 0.27 | 174,413 | -72.03% | -$3.41M | 0.21 | |
| Crinetics Pharmaceuticals, Inc. CRNX | $210M | 0.27 | 210,000 | -31.71% | -$97.5M | 33.16 | |
| Intellia Therapeutics, Inc. NTLA | $7.02M | 0.26 | 255,000 | +157.58% | +$4.29M | 1.11 | |
| Regulus Therapeutics Inc. RGLS | $490,487.00 | 0.26 | 170,308 | New | +$490,487.00 | 0.08 | |
| Fulcrum Therapeutics, Inc. FULC | $1.23M | 0.21 | 130,000 | 0% | +$0 | 0.19 | |
| Design Therapeutics, Inc. DSGN | $455,543.00 | 0.2 | 113,038 | New | +$455,543.00 | 0.07 | |
| Protagonist Therapeutics, Inc. PTGX | $3.26M | 0.19 | 112,700 | 0% | +$0 | 0.52 | |
| Repare Therapeutics Inc. RPTX | $318,212.00 | 0.16 | 67,561 | New | +$318,212.00 | 0.05 | |
| Vaxcyte, Inc. PCVX | $5.81M | 0.08 | 85,000 | -5.56% | -$341,550.00 | 0.92 | |
MorphoSys AG MOR | $1.18M | 0.04 | 65,000 | -55.17% | -$1.45M | 0.19 | |
| Glaukos Corporation GKOS | $808,631.00 | 0.02 | 8,576 | New | +$808,631.00 | 0.13 |